APP and Alzheimer disease: Ma et al. [56] similarly examined the impact of AMPK inhibition on LTP development in a genetic mouse model of AD (10–12 m old APP/PS1 mice), where hippocampal slices treated with CC (5 μM) showed significant improvements in LTP.